SI Swim on MSN6h
Winnie Harlow Is Using Her Platform to Inspire Future Generations of Female Entrepreneurs
SI Swimsuit legend Winnie Harlow had already made a name for herself before she graced the pages of the magazine in 2019. The ...
Managed Healthcare Executive13h
Long-Term Dupixent Treatment Shows Promising Results for Severe Atopic Dermatitis
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.
China Medical System: First Ruxolitinib Cream's Prescriptions For Vitiligo Issued In The Greater Bay Area
( MENAFN - ACN NewsWire) China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area ...
Incyte Announces Health Canada Approval of OPZELURA® (ruxolitinib) Cream for the Treatment of Atopic Dermatitis (AD) and Nonsegmental Vitiligo
Incyte Biosciences Canada today announced that Health Canada has granted a Notice of Compliance for OPZELURA® (ruxolitinib ...
MyChesCo on MSN5d
Transforming Lives: Innovative Treatments for Skin Conditions with XTRAC® Excimer Laser at Japanese Dermatology Seminar
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced that JMEC Co., Ltd., its long-time partner and distributor in Japan, ...
dermatologyadvisor6d
Tofacitinib Supported for Vitiligo, May Be Most Favorable Systemic JAK Inhibitor
Systemic JAK inhibitor therapy with tofacitinib was associated with the most favorable outcomes among patients with extensive vitiligo.
STRATA Skin Sciences’ XTRAC® Excimer Laser was Focus of Two Lectures at Major Japanese Annual Dermatology Conference
The first speaker at this seminar was Dr. Nobuhiro Nouchi from the Nouchi Dermatology Clinic in Japan who discussed the successful treatment of vitiligo and alopecia areata with the Company’s XTRAC ® ...